Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.

Greenwald MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, Albrecht TL, Schwartz AG.

Cancer. 2018 Nov 2. doi: 10.1002/cncr.31798. [Epub ahead of print]

PMID:
30387871
2.

Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis.

Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, Schiffer CA.

Cancer. 2018 Oct 21. doi: 10.1002/cncr.31738. [Epub ahead of print]

PMID:
30343488
3.

Decision rule approach applied to estimate occupational lead exposure in a case-control study of kidney cancer.

Callahan CL, Locke SJ, Dopart PJ, Stewart PA, Schwartz K, Ruterbusch JJ, Graubard BI, Rothman N, Hofmann JN, Purdue MP, Friesen MC.

Am J Ind Med. 2018 Nov;61(11):901-910. doi: 10.1002/ajim.22912. Epub 2018 Oct 6.

PMID:
30291640
4.

Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study.

Park HK, Schildkraut JM, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy M, Crankshaw S, Funkhouser E, Moorman PG, Peters ES, Terry P, Wang F, Ruterbusch JJ, Schwartz AG, Cote ML.

Cancer Causes Control. 2018 Nov;29(11):1081-1091. doi: 10.1007/s10552-018-1082-4. Epub 2018 Sep 29.

PMID:
30269307
5.

Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1452. doi: 10.1007/s12325-018-0767-0.

6.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.

Shaik AN, Ruterbusch JJ, Abdulfatah E, Shrestha R, Daaboul MHDF, Pardeshi V, Visscher DW, Bandyopadhyay S, Ali-Fehmi R, Cote ML.

Breast Cancer Res. 2018 Aug 9;20(1):91. doi: 10.1186/s13058-018-1027-6.

7.

Renal cell carcinoma risk associated with lower intake of micronutrients.

Bock CH, Ruterbusch JJ, Holowatyj AN, Steck SE, Van Dyke AL, Ho WJ, Cote ML, Hofmann JN, Davis F, Graubard BI, Schwartz KL, Purdue MP.

Cancer Med. 2018 Aug;7(8):4087-4097. doi: 10.1002/cam4.1639. Epub 2018 Jul 2.

8.

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1438-1451. doi: 10.1007/s12325-018-0738-5. Epub 2018 Jun 26. Erratum in: Adv Ther. 2018 Aug 16;:.

9.

Diabetes Management Among Arab Americans Who Sought Care at a Large Metropolitan Hospital System in Michigan.

Dallo FJ, Ruterbusch JJ, McCullough JR, Sreedhar S, Schwartz K, Mulhem E.

J Immigr Minor Health. 2018 Jun 25. doi: 10.1007/s10903-018-0777-7. [Epub ahead of print]

PMID:
29943204
10.

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker.

Levin RA, Lund ME, Truong Q, Wu A, Shore ND, Saltzstein DR, Concepcion RS, Paivanas TA, van Breda A, Beebe-Dimmer J, Ruterbusch JJ, Wissmueller S, Campbell DH, Walsh BJ.

Oncotarget. 2018 Apr 27;9(32):22359-22367. doi: 10.18632/oncotarget.25009. eCollection 2018 Apr 27.

11.

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.

Campbell DH, Lund ME, Nocon AL, Cozzi PJ, Frydenberg M, De Souza P, Schiller B, Beebe-Dimmer JL, Ruterbusch JJ, Walsh BJ.

PLoS One. 2018 Apr 19;13(4):e0196017. doi: 10.1371/journal.pone.0196017. eCollection 2018.

12.

Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM, Flanders SC, Barlev A, Fryzek JP, Quek RGW.

Cancer. 2018 May 15;124(10):2104-2114. doi: 10.1002/cncr.31299. Epub 2018 Mar 5.

PMID:
29505670
13.

Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.

Holowatyj AN, Cote ML, Ruterbusch JJ, Ghanem K, Schwartz AG, Vigneau FD, Gorski DH, Purrington KS.

J Clin Oncol. 2018 Mar 1;36(7):652-658. doi: 10.1200/JCO.2017.74.5448. Epub 2018 Jan 17.

PMID:
29341832
14.

Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.

Thakur MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, Beebe-Dimmer JL, Wozniak AJ.

J Thorac Oncol. 2018 Jan;13(1):46-53. doi: 10.1016/j.jtho.2017.09.1964. Epub 2017 Oct 5.

15.

Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes.

Park HK, Ruterbusch JJ, Cote ML.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1511-1518. doi: 10.1158/1055-9965.EPI-17-0290. Epub 2017 Jul 27.

16.

Leukocyte telomere length and renal cell carcinoma survival in two studies.

Callahan CL, Schwartz K, Ruterbusch JJ, Shuch B, Graubard BI, Lan Q, Cawthon R, Baccarelli AA, Chow WH, Rothman N, Hofmann JN, Purdue MP.

Br J Cancer. 2017 Aug 22;117(5):752-755. doi: 10.1038/bjc.2017.237. Epub 2017 Jul 25.

17.

Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.

Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS.

Breast Cancer Res Treat. 2017 Aug;165(1):163-168. doi: 10.1007/s10549-017-4300-y. Epub 2017 May 25.

PMID:
28547656
18.

Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.

Daum LM, Reamer EN, Ruterbusch JJ, Liu J, Holmes-Rovner M, Xu J.

J Am Board Fam Med. 2017 May-Jun;30(3):288-297. doi: 10.3122/jabfm.2017.03.160298.

19.

Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040.

Gaber C, Meza R, Ruterbusch JJ, Cote ML.

J Racial Ethn Health Disparities. 2016 Oct 17. [Epub ahead of print]

PMID:
27753051
20.

A Health Profile of Arab Americans in Michigan: A Novel Approach to Using a Hospital Administrative Database.

Dallo FJ, Ruterbusch JJ, Kirma JD, Schwartz K, Fakhouri M.

J Immigr Minor Health. 2016 Dec;18(6):1449-1454.

PMID:
26472547
21.

HER2 status and disparities in luminal breast cancers.

Holowatyj AN, Ruterbusch JJ, Ratnam M, Gorski DH, Cote ML.

Cancer Med. 2016 Aug;5(8):2109-16. doi: 10.1002/cam4.757. Epub 2016 Jun 1.

22.

Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.

Xu J, Janisse J, Ruterbusch JJ, Ager J, Liu J, Holmes-Rovner M, Schwartz KL.

Ann Fam Med. 2016 May;14(3):208-14. doi: 10.1370/afm.1926.

23.

Racial/Ethnic Disparities in Survival Among Patients With Young-Onset Colorectal Cancer.

Holowatyj AN, Ruterbusch JJ, Rozek LS, Cote ML, Stoffel EM.

J Clin Oncol. 2016 Jun 20;34(18):2148-56. doi: 10.1200/JCO.2015.65.0994. Epub 2016 May 2.

24.

Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.

Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS.

Int J Cancer. 2016 Aug 1;139(3):584-92. doi: 10.1002/ijc.30108. Epub 2016 Apr 9.

25.

Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.

Schwartz K, Ruterbusch JJ, Colt JS, Miller DC, Chow WH, Purdue MP.

Cancer Med. 2016 Feb;5(2):200-8. doi: 10.1002/cam4.578. Epub 2015 Dec 29.

26.

Contribution of health behaviors to the association between area-level socioeconomic status and cancer mortality.

Hastert TA, Ruterbusch JJ, Beresford SA, Sheppard L, White E.

Soc Sci Med. 2016 Jan;148:52-8. doi: 10.1016/j.socscimed.2015.11.023. Epub 2015 Nov 22.

27.

A case-control study of occupational sunlight exposure and renal cancer risk.

Karami S, Colt JS, Stewart PA, Schwartz K, Davis FG, Ruterbusch JJ, Chow WH, Wacholder S, Graubard BI, Purdue MP, Moore LE.

Int J Cancer. 2016 Apr 1;138(7):1626-33. doi: 10.1002/ijc.29902. Epub 2015 Nov 14.

28.

The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1407-15. doi: 10.1158/1055-9965.EPI-15-0316. Epub 2015 Aug 19.

29.

Racial differences in breast cancer survival in a large urban integrated health system.

Roseland ME, Pressler ME, Lamerato LE, Krajenta R, Ruterbusch JJ, Booza JC, Schwartz K, Simon MS.

Cancer. 2015 Oct 15;121(20):3668-75. doi: 10.1002/cncr.29523. Epub 2015 Jun 25.

30.

Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).

Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, Nicholson WK, Park AB, Petruzella S, Rebbeck TR, Setiawan VW, Signorello LB, Simon MS, Weiss NS, Wentzensen N, Yang HP, Zeleniuch-Jacquotte A, Olson SH.

Cancer Causes Control. 2015 Feb;26(2):287-296. doi: 10.1007/s10552-014-0510-3. Epub 2014 Dec 23.

31.

Vanishing endometrial cancer in hysterectomy specimens: a myth or a fact.

Ahmed QF, Gattoc L, Al-Wahab Z, Abdulfatah E, Ruterbusch JJ, Cote M, Bandyopadhyay S, Morris RT, Ali-Fehmi R.

Am J Surg Pathol. 2015 Feb;39(2):221-6. doi: 10.1097/PAS.0000000000000361.

PMID:
25517962
32.

Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML.

Breast J. 2014 Nov-Dec;20(6):571-7. doi: 10.1111/tbj.12331. Epub 2014 Sep 8.

33.

The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036. Epub 2014 Jun 19.

34.

Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Cote ML, Ruterbusch JJ, Ahmed Q, Bandyopadhyay S, Alosh B, Abdulfatah E, Seward S, Morris R, Ali-Fehmi R.

Gynecol Oncol. 2014 Apr;133(1):38-42. doi: 10.1016/j.ygyno.2014.01.013.

35.

Oropharyngeal carcinoma in young adults: an alarming national trend.

Gayar OH, Ruterbusch JJ, Elshaikh M, Cote M, Ghanem T, Hall F, Siddiqui F.

Otolaryngol Head Neck Surg. 2014 Apr;150(4):594-601. doi: 10.1177/0194599813519738. Epub 2014 Jan 22.

PMID:
24452304
36.

Differences in the cancer burden among foreign-born and US-born Arab Americans living in metropolitan Detroit.

Khan F, Ruterbusch JJ, Gomez SL, Schwartz K.

Cancer Causes Control. 2013 Nov;24(11):1955-61. doi: 10.1007/s10552-013-0271-4. Epub 2013 Sep 7.

37.

Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program.

Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwartz K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH.

Urol Oncol. 2014 Jan;32(1):23.e9-13. doi: 10.1016/j.urolonc.2012.08.011. Epub 2013 Feb 28.

38.

Enhancement and validation of an Arab surname database.

Schwartz K, Beebani G, Sedki M, Tahhan M, Ruterbusch JJ.

J Registry Manag. 2013 Winter;40(4):176-9.

39.

The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.

Hofmann JN, Schwartz K, Chow WH, Ruterbusch JJ, Shuch BM, Karami S, Rothman N, Wacholder S, Graubard BI, Colt JS, Purdue MP.

Cancer Causes Control. 2013 Jan;24(1):167-74. doi: 10.1007/s10552-012-0102-z. Epub 2012 Nov 21.

40.

An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.

Purdue MP, Moore LE, Merino MJ, Boffetta P, Colt JS, Schwartz KL, Bencko V, Davis FG, Graubard BI, Janout V, Ruterbusch JJ, Beebe-Dimmer J, Cote ML, Shuch B, Mates D, Hofmann JN, Foretova L, Rothman N, Szeszenia-Dabrowska N, Matveev V, Wacholder S, Zaridze D, Linehan WM, Brennan P, Chow WH.

Int J Cancer. 2013 Jun 1;132(11):2640-7. doi: 10.1002/ijc.27934. Epub 2013 Jan 15.

41.

Benign breast disease and the risk of subsequent breast cancer in African American women.

Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Kim E, Albashiti B, Sharaf Aldeen B, Radisky DC, Frost MH, Visscher DW, Hartmann LC, Nassar WH, Ali-Femhi R.

Cancer Prev Res (Phila). 2012 Dec;5(12):1375-80. doi: 10.1158/1940-6207.CAPR-12-0175. Epub 2012 Oct 19.

42.

Racial differences in oncogene mutations detected in early-stage low-grade endometrial cancers.

Cote ML, Atikukke G, Ruterbusch JJ, Olson SH, Sealy-Jefferson S, Rybicki BA, Alford SH, Elshaikh MA, Gaba AR, Schultz D, Haddad R, Munkarah AR, Ali-Fehmi R.

Int J Gynecol Cancer. 2012 Oct;22(8):1367-72.

43.

Body mass index and renal cell cancer: the influence of race and sex.

Beebe-Dimmer JL, Colt JS, Ruterbusch JJ, Keele GR, Purdue MP, Wacholder S, Graubard BI, Davis F, Chow WH, Schwartz KL.

Epidemiology. 2012 Nov;23(6):821-8. doi: 10.1097/EDE.0b013e31826b7fe9.

44.

A case-control study of peripheral blood mitochondrial DNA copy number and risk of renal cell carcinoma.

Purdue MP, Hofmann JN, Colt JS, Hoxha M, Ruterbusch JJ, Davis FG, Rothman N, Wacholder S, Schwartz KL, Baccarelli A, Chow WH.

PLoS One. 2012;7(8):e43149. doi: 10.1371/journal.pone.0043149. Epub 2012 Aug 24.

45.

A case-control study of occupation/industry and renal cell carcinoma risk.

Karami S, Colt JS, Schwartz K, Davis FG, Ruterbusch JJ, Munuo SS, Wacholder S, Stewart PA, Graubard BI, Rothman N, Chow WH, Purdue MP.

BMC Cancer. 2012 Aug 8;12:344. doi: 10.1186/1471-2407-12-344.

46.

Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system.

Simon MS, Lamerato L, Krajenta R, Booza JC, Ruterbusch JJ, Kunz S, Schwartz K.

Int J Breast Cancer. 2012;2012:453985. doi: 10.1155/2012/453985. Epub 2012 May 20.

47.

Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.

Cote ML, Colt JS, Schwartz KL, Wacholder S, Ruterbusch JJ, Davis F, Purdue M, Graubard BI, Chow WH.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):770-9. doi: 10.1158/1055-9965.EPI-11-1109. Epub 2012 Mar 16.

48.

Clinical/pathologic features and patient outcome in early onset endometrial carcinoma: a population based analysis and an institutional perspective from the Detroit metropolitan area, Michigan.

Semaan A, Ali-Fehmi R, Munkarah AR, Bandyopadhyay S, Morris RT, Rizk S, Mert I, Ruterbusch JJ, Cote ML.

Gynecol Oncol. 2012 Feb;124(2):265-9. doi: 10.1016/j.ygyno.2011.09.027. Epub 2011 Nov 1.

PMID:
22044605
49.

Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study.

Hofmann JN, Baccarelli A, Schwartz K, Davis FG, Ruterbusch JJ, Hoxha M, McCarthy BJ, Savage SA, Wacholder S, Rothman N, Graubard BI, Colt JS, Chow WH, Purdue MP.

Br J Cancer. 2011 Nov 22;105(11):1772-5. doi: 10.1038/bjc.2011.444. Epub 2011 Oct 27.

50.

Meat-cooking mutagens and risk of renal cell carcinoma.

Daniel CR, Schwartz KL, Colt JS, Dong LM, Ruterbusch JJ, Purdue MP, Cross AJ, Rothman N, Davis FG, Wacholder S, Graubard BI, Chow WH, Sinha R.

Br J Cancer. 2011 Sep 27;105(7):1096-104. doi: 10.1038/bjc.2011.343. Epub 2011 Sep 6.

Supplemental Content

Loading ...
Support Center